~~<i id='53B5959BB0'><strike id='53B5959BB0'><tt id='53B5959BB0'><pre id='53B5959BB0'></pre></tt></strike></i>~~

Home» focus» hotspot

hotspot

author：fashion 2025-09-30 06:16:23 Page View：1889

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approves Leqembi, a milestone in Alzheimer’s treatment
Next article： Sports medicine is finally prioritizing gender equality

explore

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

Titanic submersible: What a 'catastrophic implosion' means and what officials found

5:55TheTitansubmersible,operatedbyOceanGateExpeditionstoexplorethewreckageofthesunkenSSTitanicoffthe

As demand for Covid shots wanes, Moderna seeks its next success

RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

Personalized medicine goes far beyond genetics

AdobeSincetheHumanGenomeProjectwascompletedin2003,mostpublicconsiderationsofpersonalizedmedicinehave

WSS

hotspot

hotspot

knowledge

explore

Personalized medicine goes far beyond genetics